Session 30: Genetic Toxicology, Stem Cell Toxicology and Nanotoxicology[Symposium Program （Session）]
This conference closely aligned with global advancements in genetic toxicology and nanotoxicology, industry demands, and talent cultivation, aims to promote the integration of novel concepts, knowledge, technologies, and methodologies from life science and other toxicology fields into both genetic toxicology and nanotoxicology research and management. Currently, genetic toxicology is at a pivotal stage of its development, still grappling with significant issues such as the quantitative evaluation of genomic damage and genetic toxicity, as well as the establishment of genetic toxicity evaluation norms for nanomaterials and biological drugs. Nanotoxicology, on the other hand, faces challenges related to the safety of nanomaterials, urgently requiring the exploration of toxic mechanisms, the establishment of evaluation norms, and ensuring the safe application of nanotechnology. These challenges can only be effectively addressed through multidisciplinary infiltration, integration, collaborative efforts, and coordinated development. To this end, the conference has invited renowned experts from cancer prevention and treatment, epigenetic toxicology, nanotoxicology, and various application fields to present and discuss the latest research progress, cutting-edge theories and technologies, and strategies for achieving interdisciplinary integration. This will foster complementarity among disciplines and pave the way for further advancements in the field.
President:
NO.:1
Innovative approaches to assessing pollutant toxicity: From stem cells to AI
NO.:2
Genotoxic and carcinogenic effects of metal nanoparticles
NO.:3
The study on dual effect of tumor radiosensitization and normal tissue radioprotection based on DNA damage and repair mechanism
NO.:4
Environmental toxicants induce unexplained miscarriage
NO.:5
Evaluation and regulation on the genotoxicity of drug Impurities
